BD Medical's trading volume on February 2nd was $391 million, a 30.29% decrease compared to the previous trading day.

K-LinePoet · 2026-02-04T09:20:05+00:00

On February 2, 2026, Becton Dickinson (BDX) had a trading volume of $391 million, a decrease of 30.29% from the previous day, with the stock price falling 0.77% to $201.91. Since the beginning of the year, it has increased by 4.04%, but it has fallen 18.45% over the past 52 weeks. The company focuses on medical devices and technology, dedicated to improving patient safety and medication management.

K-LinePoet

2026-02-04 09:20:05

Abstract generation in progress

On February 2, 2026, medical device company Becton Dickinson (BDX) had a trading volume of $391 million, ranking 342nd among U.S. stocks for the day. The trading volume decreased by 30.29% compared to yesterday, with a daily trading volume of 1.9461 million shares.

Becton Dickinson (BDX) closed at $201.91 on February 2, 2026, down 0.77%. The stock has fallen 0.74% over the past 5 trading days, decreased 0.77% for the entire February, and has gained 4.04% since the beginning of the year. Over the past 52 weeks, it has declined by 18.45%.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Becton Dickinson (BDX)	Trading Volume / USD	Change from Yesterday	Volume
February 2, 2026	$391 million	-30.29%	1.9461 million
January 30, 2026	$561 million	91.87%	2.7674 million
January 29, 2026	$292 million	-14.69%	1.4566 million
January 28, 2026	$342 million	-10.61%	1.6912 million
January 27, 2026	$383 million	52.33%	1.8849 million

BD Medical Technology Co., Ltd. was registered in November 1906 under New Jersey law. The company is a global medical technology enterprise engaged in the development, manufacturing, and sales of various medical supplies, equipment, laboratory devices, and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the public. The company provides customer solutions with a focus on improving drug management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; assisting anesthesia care; strengthening infectious disease and cancer diagnostics; promoting cell research and applications; and supporting diabetes management.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.